SV Life Sciences, a Boston-based venture firm focused on healthcare investments, said today it has closed its latest Fund V at $523 million. VentureWire reported today this fund is the second-largest healthcare fund raised in 2010, after the $550 million fund that OrbiMed Advisors closed early this year. SV Life Sciences says that it plans to use its new fund to invest in therapeutics, medical devices, diagnostics, healthcare services, and health IT. And the size of its investments will be between $5 million and $35 million. The firm also has a Bay Area office in Foster City and a European office in London.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
